{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:31:42Z","timestamp":1774686702863,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.clinthera.2006.06.004","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T18:20:53Z","timestamp":1153506053000},"page":"933-942","source":"Crossref","is-referenced-by-count":52,"title":["Rosuvastatin 5 and 10 mg\/d: A pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach ldl cholesterol goals with nonstatin lipid-lowering therapies"],"prefix":"10.1016","volume":"28","author":[{"given":"Charles J.","family":"Glueck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawit","family":"Aregawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahlia","family":"Agloria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qasim","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Winiarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitender","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikanth","family":"Gogineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.06.004_bib1","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1161\/CIRCULATIONAHA.105.549857","article-title":"Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: The Minnesota Heart Survey, 1980\u20131982 to 2000\u20132002","volume":"112","author":"Arnett","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2006.06.004_bib2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2006.06.004_bib4","first-page":"1163","article-title":"Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: The CAPISH study","volume":"80","author":"Krasuski","year":"2005"},{"key":"10.1016\/j.clinthera.2006.06.004_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amjcard.2005.07.108","article-title":"Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients","volume":"97","author":"Newman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib6","doi-asserted-by":"crossref","first-page":"60E","DOI":"10.1016\/j.amjcard.2005.06.007","article-title":"Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: Benefits versus risks","volume":"96","author":"McKenney","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2006.06.004_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/14740338.3.6.547","article-title":"Rosuvastatin safety: Lessons from the FDA review and post-approval surveillance","volume":"3","author":"Davidson","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clinthera.2006.06.004_bib9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjcard.2004.06.049","article-title":"Safety of rosuvastatin","volume":"94","author":"Shepherd","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib10","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/eurheartj\/ehi482","article-title":"A comparative study with rosuvastatin in subjects with metabolic syndrome: Results of the COMETS study","volume":"26","author":"Stalenhoef","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2006.06.004_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1463-1326.2004.00450.x","article-title":"Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial","volume":"7","author":"Stender","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2006.06.004_bib12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1185\/030079905X56529","article-title":"The DISCOVERY PENTA study: A DIrect Statin COmparison of LDL-C Value\u2014an Evaluation of Rosuvastatin therapy compared with atorvastatin","volume":"21","author":"Fonseca","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2006.06.004_bib13","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1185\/030079905X74952","article-title":"LDL C\/HDL-C ratio in subjects with cardiovascular disease and a low HDLC: Results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study","volume":"21","author":"Jukema","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2006.06.004_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1368-5031.2005.00708.x","article-title":"Achieving lipid goals in real life: The Dutch DISCOVERY study","volume":"59","author":"Bots","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2006.06.004_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjcard.2005.08.026","article-title":"Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial","volume":"97","author":"Ferdinand","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ahj.2003.10.004","article-title":"Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) Study","volume":"147","author":"Schuster","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2006.06.004_bib17","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (AduIt Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2006.06.004_bib18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ajhp\/62.10.1033","article-title":"Efficacy and safety of rosuvastatin in treatment of dyslipidemia","volume":"62","author":"McKenney","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2006.06.004_bib19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinthera.2004.09.005","article-title":"Rosuvastatin in the management of hyperlipidemia","volume":"26","author":"Cheng","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2006.06.004_bib20","first-page":"1000","article-title":"A short history of the Lipid Standardization Program: How the CDC-NHLBI Lipid Standardization program (LSP) was established [in Japanese]","volume":"50","author":"Cooper","year":"2002","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.clinthera.2006.06.004_bib21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.256.17.2351","article-title":"Comparison of three cholesterol-lowering diets in normolipidemic men","volume":"256","author":"Grundy","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2006.06.004_bib22","doi-asserted-by":"crossref","first-page":"53E","DOI":"10.1016\/j.amjcard.2005.06.006","article-title":"Recent National Cholesterol Education Program Adult Treatment Panel III update: Adjustments and options","volume":"96","author":"Stone","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1742-7843.2006.pto_193.x","article-title":"Muscle symptoms associated with statins: A series of twenty patients","volume":"98","author":"Soininen","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00228-002-0508-8","article-title":"The effect of fluconazole on the pharmacokinetics of rosuvastatin","volume":"58","author":"Cooper","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2006.06.004_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA red uctase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2006.06.004_bib26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.healun.2004.07.016","article-title":"Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients","volume":"24","author":"Samman","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.clinthera.2006.06.004_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1053-2498(00)00077-2","article-title":"Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation","volume":"19","author":"Keogh","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.clinthera.2006.06.004_bib28","first-page":"4071","article-title":"Safety of statins when response is carefully monitored: A study of 336 heart recipients","volume":"37","author":"Marzoa-Rivas","year":"2005"},{"key":"10.1016\/j.clinthera.2006.06.004_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T06:03:10Z","timestamp":1555740190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806001408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0149291806001408"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.06.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}